This variant (VB) is considered more virulent and infectious; however, current antiretroviral treatment is effective against it and slows down the pr1
Service News from Infectious Diseases
The Omicron variant that appeared in South Africa in November 2021 displaced the Delta variant in 3-4 weeks in over 100 countries and now represents1
Once again, the institutional commitment of the Clinic to the recovery of the health of women victims of sexual violence is reaffirmed.
The biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to sta1
Determinants associated with a severe form of COVID-19 in people living with HIV in Catalonia identified
The results show that people with HIV with chronic comorbidities and an unsuppressed HIV viral load could be at greater risk of developing severe COV1
A trial carried out entirely in Catalonia has shown that therapy with dolutegravir plus lamivudine has an efficacy similar to that of triple therapy.1
Are you between 18 and 39 years old and do you want to take part in a PHASE I trial of a new COVID-19 vaccine?
HIPRA (Amer, Girona) is looking for volunteers aged between 18 and 39 who have not received any COVID-19 vaccine and who have not had the infection,1
5 June 2021 marks the 40th anniversary of the first description of cases of what would later be known as Acquired Immunodeficiency Syndrome (AIDS). T1
This Tuesday, a new edition of the UB-Gilead HIV-Viral Hepatitis Chair was presented. The Chair was created by the University of Barcelona, in collab1
The COVID-19 pandemic has raised concerns about the risk of people with different kinds of immunosuppression developing more serious forms of the inf1